Currently out of the existing stock ratings of Robert Leboyer, 4 are a BUY (100%).

Robert Leboyer

Work Performance Price Targets & Ratings Chart

Analyst Robert Leboyer works at NOBLE CAPITAL with a stock forecast success ratio of 100% fulfilled within 430 days on average.

Robert Leboyer’s has documented 8 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on TNXP, Tonix Pharmaceuticals Holding Corp at 24-May-2022.

Wall Street Analyst Robert Leboyer

Analyst best performing recommendations are on TNXP (TONIX PHARMACEUTICALS HOLDING CORP).
The best stock recommendation documented was for TNXP (TONIX PHARMACEUTICALS HOLDING CORP) at 4/18/2022. The price target of $19.2 was fulfilled within 28 days with a profit of $15.56 (44.76%) receiving and performance score of 15.99.

Average potential price target upside

AXLA Axcella Health TNXP Tonix Pharmaceuticals Holding Corp

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

1 years 2 months 6 days ago

0/1 (0%)

$242.25 (224.83%)

Hold

6

$5.15 (605.88%)

1 years 4 months 7 days ago

1/1 (100%)

$-4.98 (-45.36%)

1

Buy

5

$4.11 (461.80%)

1 years 5 months 20 days ago

0/1 (0%)

$3.97 (385.44%)

Buy

7

$-0.86 (-10.94%)

12

1 years 5 months 20 days ago

2/2 (100%)

$-25.13 (-72.62%)

132

Buy

1 years 8 months 19 days ago

2/2 (100%)

$-67.63 (-75.69%)

945

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Robert Leboyer?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?